SPY305.89+0.34 0.11%
DIA256.44+1.17 0.46%
IXIC9,504.43-47.62 -0.50%

Cardiff Oncology shares are trading higher after the company entered into an agreement with PoC capital to fund the Phase 2 clinical trial of its Onvansertib.

Benzinga · 05/13/2020 16:43